News and Events

A link between high citrus consumption and melanoma?

18 July 2015

Citrus consumption was associated with an increased risk of malignant melanoma in two cohorts of women and men, according to recent study results. Nevertheless, as identified by the authors and an accompanying editorial, further research is needed before current dietary advice to the public is modified.

New test improves melanoma monitoring

14 July 2015

A QIMR Berghofer Medical Research Institute scientist has found new markers for melanoma which may allow the disease to be accurately monitored via a routine blood test. Mitchell Stark from QIMR Berghofer’s Oncogenomics group said the new biomarkers could be ideally suited for monitoring tumour progression in patients diagnosed with early metastatic disease.

Two-fold variation in melanoma rates between DHBs

13 July 2015

A two-fold variation in crude and age-standardised rates (ASR) in melanoma incidence over a recent five-year period exists between DHBs, according to a new on-line Atlas in Healthcare Variation domain developed by the Health Quality & Safety Commission of New Zealand. The finding “suggests that factors other than age influence rates of melanoma incidence”.

'Exciting new immune therapy' in the news

7 July 2015

An ‘exciting new immune therapy’ and its role in creating a ‘cancer drug revolution’ is the cover story in the July 11-17 edition of the New Zealand Listener magazine. Among the drugs featured is pembrolizumab, known commercially as Keytruda, developed by Merck Sharp & Dohme.

Group-based field therapy of solar keratosis

5 July 2015

A simple process featured in a video released recently by HealthCert provides an approach that is both time- and cost-saving for patients through the provision of group therapy.

Viagra and melanoma: link inconclusive

23 June 2015

A potential link between erectile dysfunction drugs and melanoma may exist, but inconsistencies in the data make a cause-and-effect relationship questionable, an analysis of a large melanoma database suggests.

De novo vs nevus-associated melanomas: differences in aggressiveness noted

18 June 2015

De novo melanomas may be more aggressive than nevus-associated melanomas, and may differ in their molecular pathogenesis, according to findings reported as a poster at the recent ASCO conference. The authors suggest that the findings may also have implications for early detection programmes.

Practical application of new technologies for melanoma diagnosis

18 June 2015

A two-part continuing medical education article in the Journal of the American Academy of Dermatology addresses both noninvasive and molecular approaches in the practical application of new technologies for melanoma diagnosis. The series also includes CME quizzes.